MAST THERAPEUTICS

(NYSE MKT: MSTX) We are a San Diego-based biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions.
MAST THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
1995-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.masttherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(858)794-4956
Total Funding:
23 M USD
Technology used in webpage:
YouTube Google Maps API Gravity Forms Network Solutions DNS
Similar Organizations
ACEA Therapeutics
ACEA Therapeutics develops and delivers innovative treatments to improve the lives of patients with life-threatening diseases.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AesRx
AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, Aes-103 and Aes-210, which targets orphan diseases.
MiNK Therapeutics
MiNK Therapeutics provides Living drugs, Adoptive Cell Therapy, and T Cell Receptors (TCRs).
Albert Labs
Albert Labs is a pharmaceutical drug development company pursuing regulatory approval for active compounds to treat mental health.
Allos Therapeutics
Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics.
AnGes
AnGes MG, Inc. is a biopharmaceutical company with a mission to provide patients, especially those suffering from disease.
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
ASC Therapeutics
ASC Therapeutics is a biotechnology company that focuses on discovering and developing cures for intractable diseases.
Aurora BioPharma
Aurora is developing first-in-class therapies for resistant life-threatening solid tumor
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Curagen Corporation
CuraGen Corporation, a biopharmaceutical development company, develops novel therapeutics for the treatment of cancer.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Discovery Life Sciences
Discovery Life Sciences is in biospecimen analysis, procurement, and distribution for the pharmaceutical, and diagnostics industries.
Dynamis Pharmaceuticals
Dynamis Pharmaceuticals is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases.
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Elastrin Therapeutics
Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.
Etubics
Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.
Fresenius Kabi AG
Fresenius Kabi AG, a health care company, specializes in lifesaving medicines and technologies.
Genelabs Technologies
Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Hillstream BioPharma
Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer.
Himalaya Therapeutics
Himalaya Therapeutics specializes in making CAB antibodies for cancer patients that reduce tumor toxicity.
Kythera Biopharmaceuticals
Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
La jolla Pharmaceutical
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
MedGenesis Therapeutix
MedGenesis Therapeutix is a biopharmaceutical company developing life-enhancing therapeutics for patients with serious neurologic diseases.
MicroDose Therapeutx
MicroDose Therapeutx is a specialty pharmaceutical company developing next-generation drug delivery products.
Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine.
Navidea Biopharmaceuticals
Navidea develops precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases.
Neurolixis
Neurolixis is a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders.
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Octagon Research Solutions Inc.
Octagon Research Solutions acts as a virtual partner in supporting its biopharmaceutical clients throughout the entire clinical research.
Odonate Therapeutics
Odonate Therapeutics is dedicated to the development of therapeutics that improve and extend the lives of patients with cancer.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Oxyrane UK
Oxyrane UK is a biopharmaceutical company developing biosuperior enzyme replacement therapies to treat inherited diseases.
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
pH Pharma
PH Pharma's vision is focused on developing innovative healthcare products for high unmet clinical and consumer needs.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Resolution Therapeutics
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Santarus
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that
Senhwa Biosciences
Senhwa is a drug development company creating innovative therapies for cancer and related diseases.
Talecris Biotherapeutics
Talecris Biotherapeutics is a biopharmaceutical company produces and markets of plasma-derived protein therapies.
Trutino Biosciences
Trutino Biosciences is a iopharmaceutical company that develops the next generation cytokine therapies.
Viron, Inc.
Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.
Voronoi
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders.
Current Advisors List
Board_member
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-01-09 | Savara Pharmaceuticals | Savara Pharmaceuticals acquired by Mast Therapeutics | N/A |
2014-02-10 | Aires Pharmaceuticals | Aires Pharmaceuticals acquired by Mast Therapeutics | 5.2 M USD |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Mast Therapeutics
Tech Coast Angels
Tech Coast Angels investment in Post-IPO Equity - Mast Therapeutics
Official Site Inspections
http://www.masttherapeutics.com
- Host name: 206.188.209.197
- IP address: 206.188.209.197
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Mast Therapeutics"
Vast Therapeutics - Vast Therapeutics
Jan 17, 2024 Vast Therapeutics Selected to Present at the American Thoracic Society (ATS)2024 Respiratory Innovation Summit in San Diego, CA April 17, 2024See details»
Mast Therapeutics - Crunchbase Company Profile & Funding
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.See details»
Our Team - Vast Therapeutics
Mark Schoenfisch, PH.D. Founder, Chief Scientific Officer Dr. Schoenfisch, Board Member and Founder of Vast, is the Peter A. Ornstein Distinguished Professor of Chemistry at the …See details»
Breathing is Fundamental - Vast Therapeutics
Yet, there are many chronic lung diseases which strain this fundamental act. At Vast Therapeutics, we are developing breakthrough medicines to treat chronic respiratory diseases …See details»
Mast Therapeutics - M&A Summary and Business Overview
Mast Therapeutics, Inc.is a bio pharmaceutical company. It is a provider of MAST (Molecular Adhesion and Sealant Technology) platform for clinical, nonclinical and manufacturing …See details»
Vast Therapeutics - Crunchbase Company Profile & Funding
Contact Email info@vasttherapeutics.com Phone Number 919-321-1375 Vast Therapeutics develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and …See details»
Vast Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Vast Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, Disease Domain:Infectious Diseases, Technology Platform:Small ...See details»
Vast Therapeutics - LinkedIn
Vast is a preclinical airway immunology company focused on breaking the vicious cycle of infection and chronic inflammation in respiratory diseases. The Vast technology platform …See details»
Vast Therapeutics - Overview, News & Similar companies - ZoomInfo
Jan 16, 2024 Vast Therapeutics contact info: Phone number: (919) 321-1375 Website: www.vasttherapeutics.com What does Vast Therapeutics do? Vast Therapeutics, a subsidiary …See details»
Mast Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 3611 Valley Centre Drive #500. San Diego, California, 92130, United States. 858-552-0866See details»
Vast Success Biotechnology Company Limited - Drug pipelines, …
We believe our product candidates may provide an effective treatment for patients infected with Pseudomonas aeruginosa, NTM, and other drug-resistant microbes. Contact: Nathan Stasko …See details»
Vast Therapeutics Expands Leadership Team with Appointment of …
Mar 7, 2024 “Paul’s development experience will guide Vast Therapeutics as we successfully transition to a clinical-stage organization,” said Nate Stasko, Chief Executive Officer at Vast …See details»
Mast Therapeutics - Craft
See insights on Mast Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Mast Therapeutics Inc - Company Profile and News
Company profile page for Mast Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Vast Therapeutics - VentureRadar
"Vast Therapeutics, a subsidiary of KNOW Bio, LLC, is an innovative, preclinical-stage pharmaceutical company focused on helping people who suffer from severe respiratory …See details»
Mast Therapeutics - Contacts, Employees, Board Members
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.See details»
Vast Therapeutics Announces Funding from Cystic Fibrosis …
Dec 13, 2018 Vast Therapeutics Announces Funding from Cystic Fibrosis Foundation for Further Development of BIOC51 Award Supports Advancement of BIOC51 Through Toxicology …See details»
Vast Therapeutics - Craft
Vast Therapeutics (formerly Novoclem Therapeutics) is a preclinical-stage pharmaceutical company developing a nitric oxide-based therapy to treat respiratory diseases.See details»
Vast Therapeutics - VentureRadar
Vast Therapeutics, a subsidiary of KNOW Bio, LLC, is an innovative, preclinical-stage pharmaceutical company focused on helping people who suffer... ... Find out more ...See details»
Mast Therapeutics, Inc Fund Company Profile - StockInvest.us
Jan 16, 2018 3611 Valley Centre Drive. San Diego CA 92130 858-552-0866See details»